Systematic review / meta-analysis / 2019
Soy and isoflavone intakes are linked to lower mortality from cancer and cardiovascular disease.
A meta-analysis evaluated 23 prospective cohorts involving 330,826 participants. Intake of soy products was inversely associated with cancer mortality (RR 0.88, 95% CI 0.79 to 0.99) and cardiovascular mortality (ES 0.85, 95% CI 0.72 to 0.99). Additionally, each 10-mg daily increment of soy isoflavones was linked to lower risk of death from all cancers and breast cancer, while soy protein was not tied to all-cause mortality.
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis of prospective cohorts
- Who was studied
- 23 prospective cohort studies, 330,826 participants
- What was measured
- All-cause, cancer, and cardiovascular disease mortality
THE PAPER
Soy, Soy Isoflavones, and Protein Intake in Relation to Mortality from All Causes, Cancers, and Cardiovascular Diseases: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.
Nachvak SM, Moradi S, Anjom-Shoae J, Rahmani J, Nasiri M, Maleki V, Sadeghi O. J Acad Nutr Diet, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.